药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

中国药物治疗管理培训与实践专家共识

2020-03-30 中国药学相关专家小组（统称） 临床药物治疗杂志.2020.18(3):21-25.

药物治疗

《中国药物治疗管理培训与实践标准专家共识》主要包括中国药物治疗管理培训标准和中国药物治疗管理服务实践标准两个部分，由CMTM 联盟成员单位共同执行，同时也供相关政府部门、商保公司和有意参与推广普及MT

中文标题：

中国药物治疗管理培训与实践专家共识

发布机构：

中国药学相关专家小组（统称）

发布日期：

2020-03-30

简要介绍：

《中国药物治疗管理培训与实践标准专家共识》主要包括中国药物治疗管理培训标准和中国药物治疗管理服务实践标准两个部分，由CMTM 联盟成员单位共同执行，同时也供相关政府部门、商保公司和有意参与推广普及MTM 工作的其他单位研究参考。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国药物治疗管理培训与实践专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=960351c00190209f, title=中国药物治疗管理培训与实践专家共识, enTitle=, guiderFrom=临床药物治疗杂志.2020.18(3):21-25., authorId=0, author=, summary=《中国药物治疗管理培训与实践标准专家共识》主要包括中国药物治疗管理培训标准和中国药物治疗管理服务实践标准两个部分，由CMTM 联盟成员单位共同执行，同时也供相关政府部门、商保公司和有意参与推广普及MT, cover=https://img.medsci.cn/2020511/1589210160266_2020535.jpg, journalId=0, articlesId=null, associationId=854, associationName=中国药学相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Mar 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>《中国药物治疗管理培训与实践标准专家共识》主要包括中国药物治疗管理培训标准和中国药物治疗管理服务实践标准两个部分，由CMTM 联盟成员单位共同执行，同时也供相关政府部门、商保公司和有意参与推广普及MTM 工作的其他单位研究参考。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1113, guiderKeyword=药物治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1666, appHits=37, showAppHits=26, pcHits=537, showPcHits=1645, likes=0, shares=0, comments=3, approvalStatus=1, publishedTime=Mon May 11 23:57:57 CST 2020, publishedTimeString=2020-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon May 11 23:16:10 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:53:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国药物治疗管理培训与实践专家共识.pdf)])
中国药物治疗管理培训与实践专家共识.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052138, encodeId=c87e105213849, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/e91abc8f215b490688a3c8c8bc789c54/bc4d4799bb7d42a9aad906e09bd612b8.jpg, createdBy=3f872100640, createdName=滟海沉, createdTime=Thu Sep 16 23:05:50 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899337, encodeId=ef0a89933e72, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:27 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899336, encodeId=03fb899336d6, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:01 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2021-09-16 滟海沉

    棒棒的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052138, encodeId=c87e105213849, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/e91abc8f215b490688a3c8c8bc789c54/bc4d4799bb7d42a9aad906e09bd612b8.jpg, createdBy=3f872100640, createdName=滟海沉, createdTime=Thu Sep 16 23:05:50 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899337, encodeId=ef0a89933e72, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:27 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899336, encodeId=03fb899336d6, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:01 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2020-11-15 1487b89em13暂无昵称

    希望能下载学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1052138, encodeId=c87e105213849, content=棒棒的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/e91abc8f215b490688a3c8c8bc789c54/bc4d4799bb7d42a9aad906e09bd612b8.jpg, createdBy=3f872100640, createdName=滟海沉, createdTime=Thu Sep 16 23:05:50 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899337, encodeId=ef0a89933e72, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:27 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899336, encodeId=03fb899336d6, content=希望能下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cdf5306918, createdName=1487b89em13暂无昵称, createdTime=Sun Nov 15 16:32:01 CST 2020, time=2020-11-15, status=1, ipAttribution=)]
    2020-11-15 1487b89em13暂无昵称

    希望能下载学习

    0

相关指南

2020 TES临床实践指南：女性绝经后骨质疏松症的药物治疗（更新版）

美国内分泌学会(TES,The Endocrine Society) · 2020-02-18

2020 日本专家共识：抑郁症的药物治疗

国外精神科相关专家小组（统称） · 2020-01-28

2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2020-01-22

2019 BAP循证指南：精神分裂症的药物治疗（更新版）

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2019-12-12

2019 哈佛南岸计划之精神药理学规范——强迫症药物治疗流程

国外精神科相关专家小组（统称） · 2019-11-28

2019 AAN/AHS实践指南：预防儿童偏头痛的药物治疗

美国神经病学学会(AAN,American Academy of Neurology) · 2019-08-14

拓展阅读

2014 WFSBP指南：基层医疗中痴呆的药物治疗

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2014-09-08

2014 CPS共识声明：慢性神经病理性疼痛的药物治疗（修订版）

加拿大疼痛学会(CPS,Canadian Pain Society) · 2014-12-06

2016 AME立场声明：药物治疗骨质疏松症

意大利临床内分泌协会(AME,Associazione Medici Endocrinologi) · 2016-03-11

2016 ACC/AHA/HFSA临床指南：新药物治疗心力衰竭

美国心脏协会(AHA,American Heart Association) · 2016-05-20

2016 ACP临床实践指南：药物治疗与非药物治疗治疗成人重度抑郁症

美国医师协会(ACP,American College of Physicians) · 2016-02-09

2015 AGA指南：显微镜性结肠炎的药物治疗

美国胃肠病协会(AGA,American Gastroenterological Association) · 2015-11-14